DRREDDY's weekly performance was strong, with a 3.92% return, outperforming HINDUNILVR and SUNPHARMA, but underperforming DIVISLAB. The stock's volatility was relatively high at 38.65%, indicating a moderate level of risk. Despite this, the Sharpe Ratio of 0.41 suggests that the return was somewhat justified by the risk taken. The Max Drawdown of -1.09% indicates a relatively stable performance.

[Volatility: 38.65%]